De-bugging the system: could antibiotics improve liver transplant outcomes?
Jonathan S. Bromberg,1,2,3 Joseph R. Scalea,1,2,3 and Emmanuel F. Mongodin1,2,4
1Department of Surgery,
2Department of Microbiology and Immunology,
3Center for Vascular and Inflammatory Diseases, and
4Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Address correspondence to: Jonathan S. Bromberg, 22 South Greene St., S8B06; Baltimore, MD 21201, USA. Phone: 410.328.0008; Email: jbromberg@som.umaryland.edu.
Find articles by Bromberg, J. in: JCI | PubMed | Google Scholar
1Department of Surgery,
2Department of Microbiology and Immunology,
3Center for Vascular and Inflammatory Diseases, and
4Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Address correspondence to: Jonathan S. Bromberg, 22 South Greene St., S8B06; Baltimore, MD 21201, USA. Phone: 410.328.0008; Email: jbromberg@som.umaryland.edu.
Find articles by Scalea, J. in: JCI | PubMed | Google Scholar
1Department of Surgery,
2Department of Microbiology and Immunology,
3Center for Vascular and Inflammatory Diseases, and
4Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Address correspondence to: Jonathan S. Bromberg, 22 South Greene St., S8B06; Baltimore, MD 21201, USA. Phone: 410.328.0008; Email: jbromberg@som.umaryland.edu.
Find articles by
Mongodin, E.
in:
JCI
|
PubMed
|
Google Scholar
|
First published July 22, 2019 - More info
J Clin Invest. 2019;129(8):3054–3057. https://doi.org/10.1172/JCI130314.
© 2019 American Society for Clinical Investigation
Organ transplantation is now a preferred treatment for end-stage organ failure. Among the challenges for ensuring excellent clinical outcomes for transplant recipients is good initial allograft function at the time of organ implantation. This is determined in part by the functional status of the donor and donor organ, functional status of the recipient, and conduct of the operative procedure. Despite optimization of these variables, organ transplantation is still often plagued by substantial initial dysfunction, variably referred to as slow or delayed graft function, or in the most extreme cases, primary graft nonfunction necessitating urgent regrafting. In this issue of the JCI, Nakamura, Kageyama, Ito, Hirao, and colleagues investigate a potential role for the recipient’s microbiome in determining graft function after liver transplantation and demonstrate the benefits of antibiotic pretreatment in both a mouse model and in human patients.
- Purchase this article
- $10
- Purchasing this article will give you full access for the calendar year.
- Purchase Site Pass
- $25
- This will give you access to every article on the site for 24 hours.
- Online subscription
- $95
- Individual online subscriptions give you full online access for the calendar year.
- Print subscription
- $795
- Individual print subscriptions give you the print journal and full online access for the year.
- JCI This Month subscription
- $125
- JCI This Month is a 16- to 20-page overview of the articles published each month
- Subscribing to JCI This Month also gives subscribers full online access for the calendar year.
- *Price outside U.S. and Canada: $225.
Copyright © 2019 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)